医护人员接种二价mRNA SARS-CoV-2疫苗加强针后抗体应答的六个月随访
本研究对494名接种二价mRNA SARS-CoV-2疫苗加强针的医护人员随访6个月,发现抗三聚体Spike IgG基线较高,接种后1个月升高但随后6个月下降;基线免疫较低和年龄较大者抗体升高幅度更大,45份血清中XBB.1.5中和阳性从接种前23份升至6个月后35份。
要点
- 494名医护人员接种二价mRNA加强针后,抗三聚体Spike IgG在1个月升高但随后6个月下降。
- 基线免疫较低和年龄较大者抗体升高幅度更大。
- 45份血清中XBB.1.5中和阳性从接种前23份(51.1%)升至6个月后35份(77.8%)。
核心结论
- 研究提示存在显著预存免疫,可能来自既往感染、无症状暴露和多次疫苗接种。
- 基线免疫较低的个体对疫苗接种的抗体应答更强更快,且有助于提供针对新流行变异株的更广泛抗体谱。
- 这些发现为在仍处于较高风险的人群中制定未来免疫政策提供了关键见解。
研究设计与样本
- 研究对494名接受二价mRNA SARS-CoV-2疫苗加强免疫的医护人员进行了为期6个月的队列随访。
- 对其中45名医护人员的血清进行了针对BA.5和XBB.1.5亚变异株的中和试验。
主要发现
- 研究样本在基线(接种疫苗前)抗三聚体Spike IgG水平较高,接种二价加强针后1个月升高,但随后6个月下降。
- 性别、疫苗类型、同时接种季节性流感疫苗和抗N IgG血清阳性在接种后1个月对 antibody levels 无显著影响。
- 基线免疫较低和年龄较大组的个体抗体升高幅度更大。
- 接种前几乎所有血清均中和BA.5;接种前23份(51.1%)中和XBB.1.5,6个月后升至35份(77.8%)。
- 两个时间点BA.5的MNT均高于XBB.1.5,且抗三聚体S IgG水平与两种毒株的MNT相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Healthcare workers (HCW) are at increased risk for SARS-CoV-2 exposure and infection and have been preferentially prioritised in vaccination campaigns. The present study aims to monitor vaccine-induced humoral immune response over a 6-month period in a cohort of 494 HCW who received a booster immunization with bivalent mRNA SARS-CoV-2 vaccines. Overall, the study sample displayed high anti-trimeric Spike IgG levels at baseline (prior vaccine administration), which increased one month after the bivalent booster but declined over the subsequent six months. Sex, type of vaccine, concomitant seasonal flu vaccination, and anti-N IgG seropositivity had no significant impact on antibody levels one-month post-vaccination, while higher antibody increase was seen in individuals with lower baseline immunity and older age groups. Sera from 45 HCWs were tested in neutralization assays against the BA.5 and XBB.1.5 subvariants. Almost all sera neutralized BA.5 before vaccination; 23 (51.1 %) neutralized XBB.1.5 before vaccination, rising to 35 (77.8 %) after six months. MNT against BA.5 was higher than against XBB.1.5 at both time points, and anti-trimeric S IgG levels correlated with MNT for both strains. In conclusion, the present study suggests significant pre-existing immunity, possibly from prior infections, asymptomatic exposure to SARS-CoV-2, and multiple vaccine doses. We found that individuals with lower baseline immunity exhibited a stronger and faster antibody response to vaccination, which was also beneficial in providing a broader antibody repertoire against newly circulating variants. Overall, these findings offer crucial insights for shaping future immunization policies in a population that remains at elevated risk.
引用
- Fedele G, Schiavoni I, Trentini F, et al. Six-month follow-up of antibody response to bivalent mRNA SARS-CoV-2 vaccine booster in healthcare workers. Vaccine. 2025. PMID: 40743842. doi:10.1016/j.vaccine.2025.127524
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。